Monday 9 November 2026
Export MOLN’s income statement to Excel — free account
Molecular Partners AG Sponsored ADR
MOLNMolecular Partners AG Sponsored ADR’s revenue for fiscal 2024 (year ended December 2024) was $5.6 million, down 28.0% from fiscal 2023.
- Revenue
- −98.9%
- EPS
- +8.27%
- Free cash flow
- +11.1%
Quarter to September 2026, against a year earlier
3.22
0.03
−0.92%
Follow MOLN
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(57.72%) | (63.08%) | (63.89%) | (71.08%) | |
| (49.07%) | (53.96%) | (52.73%) | (58.83%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(67.69%) | (72.08%) | (77.93%) | (95.19%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.68) | (1.63) | (1.48) | (1.45) | |
Free Cash Flow |
(62.73) | (61.04) | (57.35) | (55.74) | |
Capital Expenditures |
(0.86) | — | (0.39) | (0.23) | |
| Other line items | |||||
Cash ROIC |
(29.97%) | (32.49%) | (35.84%) | (41.86%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
22.86 | 18.47 | 20.11 | 22.37 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
16.05 | 18.95 | 17.53 | 11.70 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(11.52) | (14.31) | (106.34) | (151.50) | |
Operating CF/Net income |
0.83 | 0.84 | 0.88 | 0.86 | |
Depreciation/Fixed assets |
0.41 | 0.43 | 0.46 | 0.50 | |
Capex/Depreciation |
(0.33) | 0.00 | (0.16) | (0.10) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.66) | (1.63) | (1.47) | (1.45) | |
Capex per Share |
(0.02) | 0.00 | (0.01) | (0.01) | |
Capex to Sales |
0.00 | — | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026